I-Turmeric ye-Fibromyalgia ne-Chronic Yokukhathala Syndrome

I-Turmeric iyisipuni esiphuzi eliphuzi esivame ukutholakala emaxukwini e-curry-spice. Impande, ehlobene ne-ginger, ithandwa kakhulu kuma-Indian, Thai, naseMorocco, futhi sekuyisikhathi eside isetshenziselwa imithi yesiShayina neye- Ayurvedic .

Izinzuzo zezeMpilo

I-Turmeric iqukethe i-compound ebizwa ngokuthi i-curcumin, okucwaningwayo okusikisela kungase inikeze izinzuzo eziningana zezempilo ezingasiza ekunciphiseni izimpawu ze- fibromyalgia nesifo esingapheliyo sokukhathala .

Kuze kube manje, akukho zifundo ezizihlolisisile ngokuqondene nalezi zimo.

Ngenkathi sinezocwaningo oluthile nge-turmeric / curcumin, izifundo eziningi kudingeka zenziwe ukuze zikhohlise kahle ukuthi zingenzenjani. I-spice ikholelwa ukuthi iyi:

Sekusetshenziselwa ukwelashwa kwezifo eziningi, kufaka phakathi:

Isilinganiso

Uma kuthathwa njengesisonge, i-curusin ejwayelekile ephakathi kuka-450 milligrams no-3 amagremu nsuku zonke. Amanani aphelele okusetshenziselwa okukhethekile awazange amiswe ngokucwaninga.

I-turmeric ingabuye isetshenziswe itiye ngokufaka ama-1-1.5 amagremu womsuka omisiwe imizuzu engu-15, kabili ngosuku.

I-Turmeric / Curcumin ekudleni kwakho

Ukwengeza i-curcumin ekudleni kwakho, nge-turmeric, ilula kakhulu. Kodwa-ke, kungase kube nzima ukuthola umthamo wokwelapha ngokudla okuwukuphela.

E-India, lapho i-turmeric isetshenziselwa ukudla okuningi okwejwayelekile, ukudla okulinganiselwe kokudla kuyalinganiselwa ukuthi kube phakathi kwamama-milligram angu-60 kuya kwangu-200 ngosuku.

Lokhu kuphansi kakhulu kunezindlela zokwelapha.

Okuqhamuka uma udla imishanguzo

Ucwaningo lubonise ukuthi i-turmeric / i-curcumin ingabangela ezinye imiphumela emibi, kufaka phakathi:

Ukuphepha kwe-Turmeric akusekelwe izingane.

Isixwayiso sikhuthazwa uma kudla i-turmeric ngesikhathi sokukhulelwa, ngenxa yokuthi kungenzeka ukuthi ingakhuthaza isibeletho futhi iholele ekuphumeni kwesimo sokuphuma esikhathini.

Noma nini lapho ucabangela ukwesekwa okusha, kufanele uxoxe nodokotela wakho kanye nekhemisi ukuqinisekisa ukuthi awukwenzi ukuxhumana okuyingozi noma ezinye izinkinga.

Imithombo:

Bhandarkar SS, i-Arbiser JL. I-Adv Exp Med Biol. 2007; 595: 185-195. I-Curcumin njenge-inhibitor ye-angiogenesis.

I-Brouet I, i-Ohshima H. ​​Biochem Biophys Res Commun. 1995; 206 (2): 533-540. I-Curcumin, umgqugquzeli we-anti-tumor ne-anti-inflammatory agent, evimbela ukungeniswa kwe-nitric oxide synthase kumacrophages acushiwe.

Cheng AL, Hsu CH, Lin JK, et al. I-Anticancer Res. 2001; 21 (4B): 2895-2900. Isivivinyo se-Phase I emtholampilo se-curcumin, i-agent yamakhemikhali, ezigulini ezinezilonda ezinobungozi obukhulu noma ezibulalayo.

ULal B, et al. I-Phytother Res. 2000; 14 (6): 443-447. Indima ye-curcumin e-idiopathic inflammatory orbital pseudotumours.

Perkins S, Verschoyle RD, Hill K, et al. I-Cancer Epidemiol Biomarkers Ngaphambi. 2002; 11 (6): 535-540. Ukusebenza kwe-Chemopreventive ne-pharmacokinetics ye-curcumin ku-min / + mouse, imodeli ye-polyposis ene-familial adenomatous.

Rivera-Espinoza Y, Muriel P. Liver Int. 2009 Nov; 29 (10): 1457-66. Izenzo zokwelapha ze-curcumin ezifweni zesibindi noma umonakalo.

I-Sharma RA, uGescher AJ, Steward WP. I-Eur J Cancer. 2005; 41 (13): 1955-1968. Curcumin: Indaba kuze kube manje.

Sreejayan, Rao MN. J Pharm Pharmacol. 1997; 49 (1): 105-107. I-oxide ye-nitri ishaqhaza nge-curcuminoids.